These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26700911)

  • 1. Fresh Insights into Disease Etiology and the Role of Microbial Pathogens.
    Farina A; Farina GA
    Curr Rheumatol Rep; 2016 Jan; 18(1):1. PubMed ID: 26700911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of viral infections in the etiopathogenesis of systemic sclerosis.
    Moroncini G; Mori S; Tonnini C; Gabrielli A
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):3-7. PubMed ID: 23910606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis and infections.
    Randone SB; Guiducci S; Cerinic MM
    Autoimmun Rev; 2008 Oct; 8(1):36-40. PubMed ID: 18706530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis.
    Ferri C; Arcangeletti MC; Caselli E; Zakrzewska K; Maccari C; Calderaro A; D'Accolti M; Soffritti I; Arvia R; Sighinolfi G; Artoni E; Giuggioli D
    J Autoimmun; 2021 Nov; 124():102727. PubMed ID: 34601207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
    Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
    Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story.
    Quaglia M; Merlotti G; De Andrea M; Borgogna C; Cantaluppi V
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of infectious agents in the pathogenesis of systemic sclerosis.
    Hamamdzic D; Kasman LM; LeRoy EC
    Curr Opin Rheumatol; 2002 Nov; 14(6):694-8. PubMed ID: 12410093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early inflammatory players in cutanous fibrosis.
    Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
    J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma.
    Magro CM; Nuovo G; Ferri C; Crowson AN; Giuggioli D; Sebastiani M
    J Cutan Pathol; 2004 Jan; 31(1):43-50. PubMed ID: 14675284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of pityriasis rosea with cytomegalovirus, Epstein-Barr virus and parvovirus B19 infections - a prospective case control study by polymerase chain reaction and serology.
    Chuh AA
    Eur J Dermatol; 2003; 13(1):25-8. PubMed ID: 12609777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
    Ohtsuka T; Yamazaki S
    Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate Immune Modulation Induced by EBV Lytic Infection Promotes Endothelial Cell Inflammation and Vascular Injury in Scleroderma.
    Farina A; Rosato E; York M; Gewurz BE; Trojanowska M; Farina GA
    Front Immunol; 2021; 12():651013. PubMed ID: 33953718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma.
    Farina A; Cirone M; York M; Lenna S; Padilla C; Mclaughlin S; Faggioni A; Lafyatis R; Trojanowska M; Farina GA
    J Invest Dermatol; 2014 Apr; 134(4):954-964. PubMed ID: 24129067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of infectious agents in patients with systemic sclerosis.
    Bilgin H; Kocabaş H; Keşli R
    Turk J Med Sci; 2015; 45(6):1192-7. PubMed ID: 26775370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Human Cytomegalovirus and Human Herpesvirus 6 Infection on the Expression of Factors Associated with Cell Fibrosis and Apoptosis: Clues for Implication in Systemic Sclerosis Development.
    Arcangeletti MC; D'Accolti M; Maccari C; Soffritti I; Conto F; Chezzi C; Calderaro A; Ferri C; Caselli E
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral infections and systemic sclerosis.
    Ferri C; Giuggioli D; Colaci M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-229. PubMed ID: 24295551
    [No Abstract]   [Full Text] [Related]  

  • 17. Kikuchi-Fujimoto lymphadenitis: role of parvovirus B-19, Epstein-Barr virus, human herpesvirus 6, and human herpesvirus 8.
    Rosado FG; Tang YW; Hasserjian RP; McClain CM; Wang B; Mosse CA
    Hum Pathol; 2013 Feb; 44(2):255-9. PubMed ID: 22939574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel insights on the role of the innate immune system in systemic sclerosis.
    York MR
    Expert Rev Clin Immunol; 2011 Jul; 7(4):481-9. PubMed ID: 21790291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis.
    Artlett CM; Sassi-Gaha S; Rieger JL; Boesteanu AC; Feghali-Bostwick CA; Katsikis PD
    Arthritis Rheum; 2011 Nov; 63(11):3563-74. PubMed ID: 21792841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease.
    Pastano R; Dell'Agnola C; Bason C; Gigli F; Rabascio C; Puccetti A; Tinazzi E; Cetto G; Peccatori F; Martinelli G; Lunardi C
    Int Immunol; 2012 Sep; 24(9):583-91. PubMed ID: 22773152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.